Antibody-drug conjugate containing heterocyclic compound having mutant kras protein degradation inducing effect
PH12026551894A1Pending Publication Date: 2026-09-07ASTELLAS PHARMA INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12026551894
- Authority / Receiving Office
- PH · PH
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-07-24
- Publication Date
- 2026-09-07
Need to check novelty before this filing date? Find Prior Art
No text content released.